Microcap Ledger Starling Oncology, Inc. $STLN
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Services-Offices & Clinics of Doctors of Medicine
- Headquarters
- Cerritos, CA
- Fiscal year end
- December 31
- Shares outstanding
- 101,916,115 [10-Q 2026-08-06]
What the company doesAI summary of filing
The Oncology Institute, Inc. is a community-based oncology care provider operating 65 physician-owned clinics across 17 markets in five states, plus a network of 81 independently-owned clinics and 198 contracted independent providers. The company generates revenue through fee-for-service oncology, hematology, and specialty infusion services; value-based contracts with managed care organizations and other risk-bearing entities (which accounted for over 46% of 2025 revenue); specialty pharmacy operations; and clinical trial services. As of December 31, 2025, the company managed approximately 2.0 million patients under value-based agreements. The company is revenue-generating and operates primarily through management services agreements with affiliated physician-owned professional corporations. [10-K 2026-03-12]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $308.72M | −$12.28M | $9.72M | $41.09M | [10-Q 2026-08-06] |
| FY ended Dec 2025 | $502.73M | $60.61B | −$24.59M | $33.56M | [10-K 2026-03-12] |
| FY ended Dec 2024 | $393.41M | $64.66B | −$26.54M | $49.67M | [10-K 2026-03-12] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-06 | 75,559,075 | [10-Q 2024-11-13] |
| 2025-03-10 | 75,753,229 | [10-K 2025-03-26] |
| 2025-05-07 | 89,234,112 | [10-Q 2025-05-14] |
| 2025-08-06 | 93,504,767 | [10-Q 2025-08-13] |
| 2025-11-06 | 98,381,340 | [10-Q 2025-11-13] |
| 2026-03-05 | 98,839,144 | [10-K 2026-03-12] |
| 2026-04-30 | 99,982,933 | [10-Q 2026-05-07] |
| 2026-07-30 | 101,916,115 | [10-Q 2026-08-06] |
- Shelf registration
- S-3 filed 2025-06-06; declared effective 2025-06-18 [S-3 2025-06-06]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2024-12-19. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2024-12-19 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-12-19] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-21 | Hively Brad | sell | 298,853 | $6.51 | [4 2026-08-24] |
| 2026-08-14 | Chernett Jorey | buy | 12,000 | $6.54 | [4 2026-08-17] |
| 2026-07-27 | Kaushal Mohit | grant | 33,133 | — | [4 2026-07-29] |
| 2026-07-27 | Mcgeorge Anne | grant | 41,165 | — | [4 2026-07-29] |
| 2026-07-27 | Pacala Mark L | grant | 30,120 | — | [4 2026-07-29] |
| 2026-07-27 | Stolper Mark | grant | 31,124 | — | [4 2026-07-29] |
| 2026-07-27 | Tzoumakas Kimberly Jo | grant | 29,116 | — | [4 2026-07-29] |
| 2026-07-27 | Hively Brad | grant | 27,108 | — | [4 2026-07-29] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-02 | 8-K | Director or officer change |
| 2026-08-21 | 8-K | Material agreement entered; New financial obligation |
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-08-06 | 8-K | Results of operations |
| 2026-08-03 | 8-K | Charter, bylaws or fiscal year change; Regulation FD disclosure |
| 2026-07-07 | 8-K | Material agreement entered; New financial obligation; Unregistered sale of equity |
| 2026-06-18 | 8-K | Shareholder vote results |
| 2026-05-15 | 13D/A | Beneficial ownership report (5%+ holder) |
| 2026-05-07 | 8-K | Results of operations |
| 2026-05-07 | 10-Q | Quarterly report |
| 2026-04-30 | DEF 14A | Proxy statement |
| 2026-03-16 | 13G/A | Beneficial ownership report (5%+ holder) |
Alerts for $STLN
Email me when Starling Oncology, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.